Dr. Ali Madani, Director of Machine Learning

Ali develops new deep learning models to improve drug-target interaction prediction. He completed his Ph.D. in Computational Biology at the University of Toronto, developing new feature selection approaches from omics profiles of patient tumors that are predictive of their survival and their response to drugs.

Demystifying Protein Structure Prediction Models: AlphaFold, RosettaFold, ESMFold and beyond

The purpose of this blog post is to provide an introduction to protein structure prediction models,...

CONTINUE READING

Artificial Intelligence in Drug Discovery

Artificial Intelligence (AI) systems, specifically machine learning (ML) technologies, learn how to...

CONTINUE READING

Optimization process in artificial neural networks

To become better at a task, supervised machine learning (ML) methods need to get feedback about...

CONTINUE READING

Deep Learning Across Label Confidence Distribution via Transfer Learning

When doing supervised machine learning, we would like to identify a relationship between some...

CONTINUE READING

Deep learning as intelligent communication between neurons

Our natural networks of neurons work as decision-making systems with information processing units...

CONTINUE READING

Machine Learning - Groups are collections of similar individuals

Did you notice in a conference room or event, people are grouped based on their similarities? They...

CONTINUE READING

Machine Learning - Less is enough

We don’t need to know everything for decision-making. When doctors assess if a patient is obese or...

CONTINUE READING

Machine Learning: Learning beyond living things

Industrial revolutions throughout history can be defined as pivotal stages in an advancing society,...

CONTINUE READING